A new heterologous fibrin sealant as scaffold to recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins for the repair of tibial bone defects

被引:37
|
作者
Machado, Eduardo Gomes [1 ]
Mardegan Issa, Joao Paulo [2 ]
Tocchini de Figueiredo, Fellipe Augusto [2 ]
dos Santos, Geovane Ribeiro [1 ]
Galdeano, Ewerton Alexandre [1 ]
Alves, Mariana Carla [1 ]
Chacon, Erivelto Luis [1 ]
Ferreira Junior, Rui Seabra [3 ]
Barraviera, Benedito [3 ]
da Cunha, Marcelo Rodrigues [1 ]
机构
[1] Sch Med Jundiai, Dept Morphol & Pathol, BR-13202550 Jundiai, SP, Brazil
[2] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Stomatol & Physiol, BR-14040904 Ribeirao Preto, SP, Brazil
[3] Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
关键词
Fibrin; Sealant; Scaffold; BMP-2; Natural latex; Protein P-1; SNAKE-VENOM; GLUE; CELL; COMPOSITES; VIABILITY; BMP-2;
D O I
10.1016/j.acthis.2015.03.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tissue engineering has special interest in bone tissue aiming at future medical applications Studies have focused on recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins due to the osteogenic properties of rhBMP-2 and the angiogenic characteristic of fraction 1 protein (P-1) extracted from the rubber tree Hevea brasiliensis. Furthermore, heterologous fibrin sealant (FS) has been shown as a promising alternative in regenerative therapies. The aim of this study was to evaluate these substances for the repair of bone defects in rats. A bone defect measuring 3 mm in diameter was created in the proximal metaphysis of the left tibia of 60 rats and was implanted with rhBMP-2 or P-1 in combination with a new heterologous FS derived from snake venom. The animals were divided into six groups: control (unfilled bone defect), rhBMP-2 (defect filled with 5 mu g rhBMP-2), P-1 (defect filled with 5 mu g P-1), FS (defect filled with 8 mu g FS), FS/rhBMP-2 (defect filled with 8 mu g FS and 5 mu g rhBMP-2), FS/P-1 (defect filled with 8 mu g FS and 5 mu g P-1). The animals were sacrificed 2 and 6 weeks after surgery. The newly formed bone projected from the margins of the original bone and exhibited trabecular morphology and a disorganized arrangement of osteocyte lacunae. Immunohistochemical analysis showed intense expression of osteocalcin in all groups. Histometric analysis revealed a significant difference in all groups after 2 weeks (p < 0.05), except for the rhBMP-2 and FS/rhBMP-2 groups (p > 0.05). A statistically significant difference (p < 0.05) was observed in all groups after 6 weeks in relation to the volume of newly formed bone in the surgical area. In conclusion, the new heterologous fibrin sealant was found to be biocompatible and the combination with rhBMP-2 showed the highest osteogenic and osteoconductive capacity for bone healing. These findings suggest a promising application of this combination in the regeneration surgery. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 50 条
  • [21] Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts
    Chin, M
    Ng, T
    Tom, WK
    Carstens, M
    JOURNAL OF CRANIOFACIAL SURGERY, 2005, 16 (05) : 778 - 789
  • [22] Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs
    Jürgen Becker
    Axel Kirsch
    Frank Schwarz
    Maria Chatzinikolaidou
    Daniel Rothamel
    Vojislav Lekovic
    Herbert Peter Jennissen
    Clinical Oral Investigations, 2006, 10 : 217 - 224
  • [23] De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation
    Boyne, PJ
    Lilly, LC
    Marx, RE
    Moy, PK
    Nevins, M
    Spagnoli, DB
    Triplett, RG
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (12) : 1693 - 1707
  • [24] Scientific evidence on the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in oral and maxillofacial surgery
    Gomes-Ferreira P.H.S.
    Okamoto R.
    Ferreira S.
    De Oliveira D.
    Momesso G.A.C.
    Faverani L.P.
    Oral and Maxillofacial Surgery, 2016, 20 (3) : 223 - 232
  • [25] Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly
    Hoffmann, Martin F.
    Jones, Clifford B.
    Sietsema, Debra L.
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2013, 8
  • [26] Recombinant human bone morphogenetic protein-2 (rhBMP-2) in the treatment of mandibular sequelae after tumor resection
    Zétola A.
    Ferreira F.M.
    Larson R.
    Shibli J.A.
    Oral and Maxillofacial Surgery, 2011, 15 (3) : 169 - 174
  • [27] Current Status of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Maxillofacial Surgery: Should It Be Continued?
    On, Sung-Woon
    Park, Sang-Yoon
    Yi, Sang-Min
    Park, In-Young
    Byun, Soo-Hwan
    Yang, Byoung-Eun
    BIOENGINEERING-BASEL, 2023, 10 (09):
  • [28] Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly
    Martin F Hoffmann
    Clifford B Jones
    Debra L Sietsema
    Journal of Orthopaedic Surgery and Research, 8
  • [29] A new mechanism explaining the sustained effect of Bone Morphogenetic Protein-2 (rhBMP-2) during reconstruction of segmental bone defects
    El-Awady, Ahmed Rifaat
    Hussein, Khaled Mohamed
    Zakhary, Ibrahim
    Emam, Hany
    Elsalanty, Mohammed
    FASEB JOURNAL, 2010, 24
  • [30] Prefabrication of vascularized bone flap induced by recombinant human bone morphogenetic protein 2 (rhBMP-2)
    Alam, MI
    Asahina, I
    Seto, I
    Oda, M
    Enomoto, S
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 32 (05) : 508 - 514